SIX

Digital Pathology Image Artifact Detection Software Device

Product code
SIX
Device name
Digital Pathology Image Artifact Detection Software Device
Device class
Class 2
21 CFR
21 CFR 864.3700
Medical specialty
Pathology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1

FDA classification definition

Digital Pathology Image Artifact Detection Software device is an artificial intelligence-based software intended to identify specific artifacts in scanned digital whole slide images (WSIs) of pathology slides prepared from human samples. It is intended to identify WSIs that should undergo further evaluation for image quality prior to diagnostic review of the images by pathologists. Device output is not intended for use in diagnosis, prognosis, or prediction of disease.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-08-07.

NumberDecision dateApplicantDevice nameSummary
K2535612026-08-07Leica Biosystems Imaging, Inc.Aperio iQC DX SoftwarePDF

1 summaries are archived here for direct download.

Official FDA classification page: SIX
Classification and pathway per current FDA publications. Data from openFDA (CC0).